PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Tischer, J.* ; Engel, N.* ; Fritsch, S.* ; Prevalsek, D.* ; Hubmann, M.* ; Schulz, C.* ; Zoellner, A.-K.* ; Bücklein, V.L.* ; Reibke, R.* ; Mumm, F.* ; Rieger, C.T.* ; Hill, W.* ; Ledderose, G.* ; Stemmler, H.J.* ; Köhnke, T.* ; Jäger, G.* ; Kolb, H.J.* ; Schmid, C.* ; Moosmann, A. ; Hausmann, A.*

Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: Incidence in the context of immune recovery in two different transplantation settings.

Ann. Hematol. 94, 1677-1688 (2015)
Publ. Version/Full Text DOI
Open Access Gold
We retrospectively compared the incidence of virus infections and outcome in the context of immune reconstitution in two different HLA-haploidentical transplantation (haplo-HSCT) settings. The first was a combined T-cell-replete and T-cell-deplete approach using antithymocyte globulin (ATG) prior to transplantation in patients with hematological diseases (cTCR/TCD group, 28 patients; median age 31 years). The second was a T-cell-replete (TCR) approach using high-dose posttransplantation cyclophosphamide (TCR/PTCY group, 27 patients; median age 43 years). The incidence of herpesvirus infection was markedly lower in the TCR/PTCY (22 %) than in the cTCR/TCD group (93 %). Recovery of CD4+ T cells on day +100 was faster in the TCR/PTCY group. CMV reactivation was 30 % in the TCR/PTCY compared to 57 % in the cTCR/TCD group, and control with antiviral treatment was superior after TCR/PTCY transplantation (100 vs 50 % cTCR/TCD). Twenty-five percent of the patients in the cTCR/TCD group but no patient in the TCR/PTCY group developed PTLD. While 1-year OS was not different (TCR/PTCY 59 % vs cTCR/TCD 39 %; p = 0.28), virus infection-related mortality (VIRM) was significantly lower after TCR/PTCY transplantation (1-year VIRM, 0 % TCR/PTCY vs 29 % cTCR/TCD; p = 0.009). On day +100, predictors of better OS were lymphocytes >300/μl, CD3+ T cells >200/μl, and CD4+ T cells >150/μl, whereas the application of steroids >1 mg/kg was correlated with worse outcome. Our results suggest that by presumably preserving antiviral immunity and allowing fast immune recovery of CD4+ T cells, the TCR approach using posttransplantation cyclophosphamide is well suited to handle the important issue of herpesvirus infection after haplo-HSCT.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.634
0.941
38
45
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Herpes Virus Infection ; High-dose Cyclophosphamide Posttransplantation ; Hla-haploidentical Hematopoietic Stem Cell Transplantation ; Immune Reconstitution ; T-cell-replete ; Virus Infection; Bone-marrow-transplantation; Versus-host-disease; Identical Sibling Transplantation; Cord Blood Transplantation; Risk Acute-leukemia; Peripheral-blood; Posttransplantation Cyclophosphamide; Hematologic Malignancies; Allogeneic Transplantation; Viral-infections
Language english
Publication Year 2015
HGF-reported in Year 2015
ISSN (print) / ISBN 0939-5555
e-ISSN 1432-0584
Journal Annals of Hematology
Quellenangaben Volume: 94, Issue: 10, Pages: 1677-1688 Article Number: , Supplement: ,
Publisher Springer
Publishing Place New York
Reviewing status Peer reviewed
Institute(s) CCG Immunooncology (AGV-KIO)
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-521700-001
DOI 10.1007/s00277-015-2423-y
WOS ID WOS:000360665000007
Scopus ID 84941026063
Scopus ID 84930609005
Erfassungsdatum 2015-06-19
[➜Report correction]